Caraco Pharmaceutical Laboratories, Ltd. (CPD) Markets Nicardipine Hydrochloride Injection
11/18/2009 11:02:19 AM
More...
|
Caraco Pharmaceutical Laboratories, Ltd. (CPD) Sales, Profits Fall; Indefinite Layoffs of Approximately 430 Employees
10/27/2009 10:44:42 AM
More...
|
Caraco Pharmaceutical Laboratories, Ltd. (CPD) Closes Asset Purchase Agreement with Forest Laboratories, Inc. (FRX) to Settle Lexapro(R) (escitalopram oxalate) ANDA Patent Litigation
10/2/2009 11:15:44 AM
More...
|
Caraco Pharmaceutical Laboratories, Ltd. (CPD) Enters Into Consent Decree with FDA Providing Path to Resume Manufacturing Operations
9/30/2009 9:03:36 AM
More...
|
Caraco Pharmaceutical Laboratories, Ltd. (CPD) Announces Appointment of F. Folsom Bell to Board of Directors
9/15/2009 10:42:36 AM
More...
|
Caraco Pharmaceutical Laboratories, Ltd. (CPD) Announces Reversal of Summary Judgment in Ultracet(R) ANDA Patent Litigation
8/27/2009 9:30:39 AM
More...
|
Caraco Pharmaceutical Laboratories, Ltd. (CPD) Markets Generic Imitrex(R) Tablets
8/12/2009 9:40:38 AM
More...
|
Caraco Pharmaceutical Laboratories, Ltd. (CPD) Announces Settlement of Ethyol(R) ANDA Patent Litigation
8/3/2009 9:08:29 AM
More...
|
Caraco Pharmaceutical Laboratories, Ltd. (CPD) Reports Results for the First Quarter of Fiscal Year 2010
7/29/2009 9:27:05 AM
More...
|
Caraco Pharmaceutical Laboratories, Ltd. (CPD) Announces Change to Executive Team as Jitendra N. Doshi Assumes Position of CEO
7/29/2009 7:43:31 AM
More...
|
|